NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024
Awarded by NHS England · to Gilead Sciences Limited · 2024-10-28T00:00:00Z · £626,522,476
Description
Project title: NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) for the treatment of HIV (Lot 1) & For the provision of a service to supply over labelled Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) Packs for the prevention of HIV (Lot 2) 1st November 2024 Offer reference number: CM/PHS/24/5709 Period of framework agreement: 1st November 2024 to 31st October 2026 with an option to extend (at the Authority's discretion) for a further period (or periods)…
- Supplier
- Gilead Sciences Limited
- Buyer
- NHS England
- Value
- £626,522,476
- Category (CPV)
- Pharmaceutical products
- Award date
- 2024-10-28T00:00:00Z
- Buyer constituency
- runcorn-and-helsby
Full CPV hierarchy, related awards from the same supplier and buyer, and any declared MP interest overlaps load below when JavaScript is enabled.